Status of vitamin D, Antimicrobial peptide cathelicidin and t helper‑associated cytokines in patients with diabetes mellitus and pulmonary tuberculosis

Abstract

Pulmonary tuberculosis (PTB) is a high burden infectious disease in China. The immune function is damaged in patients with diabetes mellitus (DM) who are easy to infect with Mycobacterium tuberculosis (Mtb). The growth of Mtb has been shown to be restrained following the administration of vitamin D and antimicrobial peptide cathelicidin (LL‑37); however, the effect in patients with DM and PTB remains unclear. Vitamin D can regulate the immune system through Vitamin D receptors expressed in T helper (Th) cells. The aim of the present study was to analyze the status and correlations of vitamin D, LL‑37 and Th‑associated cytokines in patients with PTB or PTB with DM (DMPTB). Serum 25‑hydroxyvi­tamin D3 [25(OH)D3] levels were measured by liquid chromatography‑tandem mass spectrometry, while plasma LL-37 levels were analyzed using a solid‑phase enzyme‑linked immunosorbent assay. Flow cytometry was used to analyze the levels of Th cytokines, including Th1‑associated IFN‑γ, Th2‑associated IL‑4 and Th17‑associated IL‑17. The results revealed that patients with PTB and DMPTB were vitamin D deficient or had insufficient vitamin D levels. Furthermore, the levels of LL‑37, IFN‑γ, IL‑4 and IL‑17 were higher in the PTB and DMPTB groups when compared with the normal controls. These results indicated that vitamin D supplementa­tion is necessary for PTB and DMPTB patients. In addition, LL‑37, IFN‑γ and IL‑17 may be diagnostic indexes that become elevated in the compensatory response caused by Mtb infection. Vitamin D can regulate the immune status in patients suffering from PTB.